Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Probiotic Modulation of Enteral Dysbiosis on dIsease Activity in Patients With PSoriatic Arthritis

NCT04588623 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04588623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04588623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Probiotic Modulation of Enteral Dysbiosis on dIsease Activity in Patients With PSoriatic Arthritis
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
November 25, 2020
Completion date
March 14, 2023
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis